NZ511117A - Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia - Google Patents

Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Info

Publication number
NZ511117A
NZ511117A NZ511117A NZ51111799A NZ511117A NZ 511117 A NZ511117 A NZ 511117A NZ 511117 A NZ511117 A NZ 511117A NZ 51111799 A NZ51111799 A NZ 51111799A NZ 511117 A NZ511117 A NZ 511117A
Authority
NZ
New Zealand
Prior art keywords
prucalopride
medicament
manufacture
treatment
dyspepsia
Prior art date
Application number
NZ511117A
Inventor
Joannes Adrianus Jac Schuurkes
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NZ511117A publication Critical patent/NZ511117A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

Described is the use of prucalopride or a pharmaceutically acceptable addition salt thereof for the manufacture of a medicament for the treatment of patients having dyspeptic symptoms due to a decreased motility of the colon. The dyspeptic symptoms comprise lack of appetite, the feeling of fullness, early satiety, nausea and vomiting, and bloating or gaseous eructation.
NZ511117A 1998-11-23 1999-11-16 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia NZ511117A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203943 1998-11-23
PCT/EP1999/009048 WO2000030640A1 (en) 1998-11-23 1999-11-16 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Publications (1)

Publication Number Publication Date
NZ511117A true NZ511117A (en) 2002-11-26

Family

ID=8234369

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ511117A NZ511117A (en) 1998-11-23 1999-11-16 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Country Status (7)

Country Link
EP (1) EP1135130A1 (en)
JP (1) JP2002530334A (en)
KR (1) KR20010080025A (en)
AU (1) AU770580B2 (en)
CA (1) CA2352278A1 (en)
NZ (1) NZ511117A (en)
WO (1) WO2000030640A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
CA2471729C (en) * 2002-01-16 2010-03-23 Janssen Pharmaceutica N.V. Prucalopride-n-oxide
KR20120037035A (en) * 2002-04-08 2012-04-18 제리아 신야쿠 고교 가부시키 가이샤 Therapeutic agent for food competence disorder in stomach

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU1385700A (en) 2000-06-13
CA2352278A1 (en) 2000-06-02
WO2000030640A1 (en) 2000-06-02
JP2002530334A (en) 2002-09-17
KR20010080025A (en) 2001-08-22
AU770580B2 (en) 2004-02-26
EP1135130A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
MXPA04003666A (en) Use of flibanserin in the treatment of sexual disorders.
EP1946775A3 (en) Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
GB0001309D0 (en) Valve arrangement
PL367277A1 (en) Methods of making sustained release formulations of oxymorphone related applications
MXPA04002714A (en) Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug.
WO1999044608A8 (en) New use
NZ515339A (en) Use of macrolide compounds for the treatment of dry eye
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
EP1440691A3 (en) Treatment of neurotic disorders
AU3258801A (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
MXPA03011317A (en) Swallow tablet comprising paracetamol.
NZ511117A (en) Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
ES2172481A1 (en) Pharmaceutical composition containing citalopram
EP1542672A4 (en) R-bambuterol, its preparation and therapeutic uses
PL321779A1 (en) Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis
GB0020504D0 (en) Therapeutic method
NO991551L (en) Use of tetrahydrobenz (cd) indole-6-carboxamides in the preparation of drugs for the prevention of emesis and treatment of sexual dysfunction
MD20020265A (en) Calcium-containing pharmaceutical composition
IL170519A (en) Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
HUP0004461A2 (en) Use of apolipoprotein b secretion/microsomal triglyceride transfer protein inhibitor for producing pharmaceutical composition and these pharmaceutical compositions
CA2481602A1 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1161948A3 (en) Pharmaceutical or food composition for treatment of brain edema
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)